|
|
Latest Story |
Ampio Announces Voluntary Delisting and SEC Deregistration |
PR Newswire |
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announcedthat its Board of Directors determined to voluntarily delist its common stock from the NYSE American and deregister its common stock in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). |
Full Story → |
Headline News |
Ampio Provides Update on Results from Pre-IND Enabling Studies |
5:45p ET February 14 '24 PR Newswire |
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions |
4:15p ET January 11 '24 PR Newswire |
More News → |
|
March 27 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, March 27 '24. |